Browse Articles

Discover research articles across all indexed journals

Insights into how JIP3 and JIP4 adaptor proteins relieve the auto-inhibited form of the kinesin-1 motor

Journal of Biological Chemistry Fernando Vilela, Mélanie Chenon, Valérie Campanacci et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113355

Real-world efficacy and survival outcomes of novel targeted therapies in advanced hepatocellular carcinoma from low- and middle-income countries.

Journal of Clinical Oncology Aleena Nazar, Amjad Zafar, Abdul Rehman Shahid Khan et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.99

99 Background: Advanced hepatocellular carcinoma (aHCC) has a dismal prognosis, with a median survival of 8-10 months. Immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) are now the standard of care for patients with aHCC. Limited information is available on access to and efficacy of new targeted treatments, response patterns, and survival among patients from lower-middle-income countries (LMICs) in the era of new therapies. Methods: This retrospective study included 666 patients with advanced HCC treated at two tertiary care hospitals. Baselines included age, gender, etiology of liver disease, socioeconomic status, ECOG performance status, Child-Pugh score, BCLC stage, and cirrhosis. Systemic treatments included tyrosine kinase inhibitors and immunotherapy-based regimens. Patients who had received prior or additional locoregional therapies. Multivariable logistic regression analysis was performed to identify predictors of treatment response. Overall survival (OS) was estimated using Kaplan-Meier curves. Results: A total of 666 patients with advanced hepatocellular carcinoma were included. The mean age at diagnosis was 60.23 ± 9.38 years. Male patients accounted for 484 (72.7%), whereas female patients accounted for 182 (27.3%) of the cohort. The most common underlying etiology of liver disease was HCV (81.6%). At presentation, 532 patients (75%) had Child-Pugh A. TKI was administered to 545 patients (81.8%), including sorafenib in 298 patients (45.1%) and lenvatinib in 247 patients (38.7%). Immunotherapy was received by 121 patients (18.2%). Locoregional therapies were used in 146 patients (21.9%) either prior to or alongside systemic therapy. On multivariable logistic regression analysis, ECOG performance status and hepatic function were independently associated with better survival in patients. Median OS was 12 months. With immunotherapy, OS improved to 18 months, compared with 12 and 10 months with Lenvatinib and Sorafenib, respectively. Conclusions: ICIs significantly improved the OS in HCC. The costs of IO therapies need to be significantly reduced to make this therapy a viable option for the vast majority of our patients in LMICs. We are planning prospective clinical trials to evaluate the efficacy and feasibility of low-dose immunotherapy, with the rationale of expanding access to immunotherapy for patients who are unable to afford standard-dose treatment.

Chirality-Magnetism Coupling for Spin-Catalytic Oxygen Evolution

Journal of the American Chemical Society Shiyi Chen, Tianzuo Wang, Kang Xue et al. Jul 01, 2026 DOI: 10.1021/jacs.6c05629

A Shared Neural Mechanism for Abstract Grammatical Computations across Languages in Bilinguals

Journal of Neuroscience Xuanyi Jessica Chen, Esti Blanco-Elorrieta Jul 01, 2026 DOI: 10.1523/jneurosci.2341-25.2026

A central question in cognitive neuroscience is how the brain implements abstract computations that must generalize across superficially different inputs. Language provides a strong test case: the same grammatical operation, such as pluralization, can be realized through distinct rules and forms across languages. Whether such transformations rely on language-specific neural systems or on abstract mechanisms that generalize across linguistic contexts remains unresolved. Crucially, these transformations must be computed online and integrated into speech planning within a tightly constrained time window. Using magnetoencephalography, we tracked the millisecond dynamics of grammatical word-form transformations during seminaturalistic phrase completion in humans of both sexes. Highly proficient Spanish–English bilinguals produced singular and plural noun forms in both languages in a design that fully orthogonalized semantic number, phonological changes, grammatical inflection, and produced language. Adjusting words to fit their grammatical context engaged a left-lateralized frontotemporal network beginning ∼100 ms after cue onset. Multivariate decoding revealed that the neural patterns supporting this computation generalized across languages, across different surface plural forms, and to pseudowords, demonstrating that abstractly equivalent operations are instantiated in the same neural substrates despite differences in linguistic form. Together, these findings provide time-resolved neural evidence for a language-general computational mechanism, showing that the brain implements grammatical transformations as abstract, generative operations. More broadly, they show how bilingualism can be used to probe general principles of neural organization, revealing how abstract computations may be shared and reused across representational systems.

Steric Coordination Modulated Iodine Chemistry With Four‐Electron Conversion for Zinc‐Iodine Batteries

Advanced Materials Shuai Wang, Haoran Wang, Yujue Yang et al. Jul 01, 2026 DOI: 10.1002/adma.73681

ABSTRACT The advancement of high‐voltage aqueous zinc‐iodine batteries is impeded by the instability of I + intermediates during the conversion process, which suffers from hydrolysis and poor reversibility in conventional electrolytes. To overcome these challenges, we propose a steric coordination strategy employing Cl − and sulfonate‐rich TES − ions to modulate the coordination environment of I + ions. Cl − ions activate I + ions through halide coordination, while the steric‐hindrance effect of TES − within the TES‐I‐Cl coordination structure effectively shields I + ions from nucleophilic attacks by water‐derived hydroxyl groups, collectively facilitating the reversible I − /I 0 /I + four‐electron conversion. Concurrently, adsorbed ions (TES − , Ch + , Cl − ) establish an electrostatic shielding layer to homogenize zinc deposition and form a dehydrated electric double layer to mitigate zinc corrosion. Moreover, the disruption of H‐bond networks between the water molecules induced by the additives reduces the water activity, further suppressing I + hydrolysis and water dissociation. Benefiting from these synergetic effects, the zinc‐iodine battery achieves highly reversible and stable iodine chemistry, including a high‐rate capability and long‐term cycling stability over 42 000 cycles (capacity retention: ∼70%). This work provides fundamental insights into ion coordination chemistry for designing high‐energy‐density aqueous iodine storage.

Estrogen promotes glycolysis through the ERα-PFKL axis in chicken hierarchical follicular granulosa cells

Journal of Biological Chemistry Yu Ji, Mengjia Xin, Caiyun Sun et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113321

The HYPCON 3 Trial: A phase II/III randomized study evaluating hypo-fractionated accelerated versus conventional fractionated adjuvant radiation therapy in head and neck malignancies.

Journal of Clinical Oncology Aman Sharma, Smriti Panda, Naveen Kumar et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.tps244

TPS244 Background: Postoperative radiotherapy (PORT) for intermediate-risk head and neck squamous cell carcinoma (HNSCC) conventionally requires 6 weeks (60 Gy/30 fractions). In high-volume settings, prolonged schedules contribute to treatment delays, non-compliance, and resource strain. Hypofractionation is established in several solid tumors, and emerging data from the HYPNO trial and HYPORT study suggest that moderate hypofractionation is oncologically sound and well tolerated. HYPCON III evaluates whether PORT duration can be safely reduced by 50% without compromising loco-regional control (LRC). Methods: HYPCON III is a prospective, randomized, phase II/III non-inferiority trial enrolling 369 patients with resected pT1–4 squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx with intermediate-risk features (positive nodes without ENE, PNI, LVSI, or close margins). Patients are randomized 1:2 to: Arm A: 60 Gy in 30 fractions over 6 weeks (n=133) Arm B: 45 Gy in 15 fractions over 3 weeks (n=246) All patients receive swallowing-sparing IMRT/VMAT with daily IGRT and structured organ-at-risk constraints. Stratification factors include primary site, T stage, and unilateral versus bilateral neck irradiation. The primary endpoint is 24-month LRC. Secondary endpoints include disease-free survival, overall survival, acute and late toxicity (RTOG, LENT-SOMA), swallowing outcomes (MDADI), and quality of life (EORTC QLQ-C30, HN35). Statistical Design: Assuming a 2-year LRC of 70% in the standard arm, the study is powered at 90% (α=0.05) to test non-inferiority within a 5% margin, incorporating 10% attrition. Impact: If non-inferiority is demonstrated, HYPCON III will support a 3-week PORT regimen as a new standard for intermediate-risk HNSCC—doubling radiotherapy capacity, reducing patient burden, and maintaining oncologic and functional outcomes. This strategy has immediate scalability for resource-constrained and high-volume centers globally.

Ligand-Mediated Defects Unlock Fast and Regenerable CO <sub>2</sub> Capture in NICS-24 Metal–Organic Framework

Journal of the American Chemical Society Klara Klemenčič, Petar Djinović, Miha Okorn et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04820

Second‐Harmonic Hyper‐Mie Optical Activity Enables Closed‐Loop Chiral Photochemistry

Advanced Materials Hoyeon Choi, Kody Whisnant, Ben J. Olohan et al. Jul 01, 2026 DOI: 10.1002/adma.73593

ABSTRACT Photochemistry promises sustainable chemical processing but typically depends on ultraviolet light with limited selectivity and penetration. We report nonlinear chiral photochemistry, where femtosecond infrared pulses are frequency‐doubled to both drive and track a transformation of chiral CdTe/CdO nanohelices into CdO nanospheroids. Circularly polarized light induces a controlled oxidation sequence monitored in real time through second‐harmonic scattering intensity and chiroptical contrast. As the CdO shell fractures and exposes non‐centrosymmetric CdTe, second‐harmonic intensity rises twenty‐fold, polarization reverses, and characteristic CdTe photoluminescence emerges. These findings are enabled by the experimental observation of the second‐harmonic hyper‐Mie optical activity effect, which completes a suite of nonlinear chiroptical scattering phenomena predicted over 45 years ago. Our results offer a spatially confined, selective, and temporally‐resolved method for material transformation.

Peptidoglycan permease AmpG1 couples lytic transglycosylase activity to muropeptide import in Acinetobacter baumannii

Journal of Biological Chemistry Taeyeong Kim, Reagan Lee, Yerim Park et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113362

Predictive scoring systems for molecular response assessment in pediatric chronic-phase chronic myeloid leukemia.

Journal of Clinical Oncology Xingchen Wang, Wenbin An, Fenying Zhao et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.256

256 Background: For pediatric patients with chronic myeloid leukemia (CML), accurately predicting at the start of imatinib therapy the likelihood of achieving a deep molecular response (DMR; at least MR4) is clinically important and may inform treatment goals and strategies. Methods: We analyzed 98 consecutive children with chronic-phase CML treated with frontline imatinib as a training cohort. Cumulative incidence functions were estimated and Fine–Gray subdistribution hazard models were used for univariable and multivariable analyses to identify covariates associated with MR4. A predictive scoring system was derived from the final multivariable Fine–Gray model. Results: In univariable analyses, older age, higher WBC, lower hemoglobin, lower platelet count, higher peripheral blood basophils, larger spleen size, and a lower 0–3-month BCR::ABL1 log-reduction were significantly associated with a lower cumulative incidence of DMR (all P &lt; 0.05). In the multivariable Fine–Gray model, a lower 0–3-month BCR::ABL1 log-reduction (P &lt; 0.001) and higher baseline WBC (P = 0.002) remained independently associated with a lower likelihood of achieving DMR. We developed a DMR predictive score using the final model coefficients: DMRscore = 0.6903 × (0–3-month BCR::ABL1 log-reduction) –0.3019 ×(WBC/100). Patients were stratified into low-, intermediate-, and high-score groups according to score tertiles: low (DMRscore ≤ −0.1389, n = 32, 33.3%), intermediate (−0.1389 &lt; DMRscore &lt; 0.9594, n = 32, 33.3%), and high (DMRscore ≥0.9594, n = 32, 33.3%). The cumulative incidence of DMR differed significantly across groups (Gray test P &lt; 0.001); at 24 months, the DMR cumulative incidence was 22.6%, 69.3%, and 82.9% in the low-, intermediate-, and high-score groups, respectively. The model showed good discrimination with time-dependent AUROC values of 0.90, 0.84, and 0.80 at 12, 24, and 36 months, respectively, and favorable predictive accuracy (Brier score: 0.1555/0.1983/0.2114 at 12/24/36 months). Conclusions: We developed a MR4 risk score using routine clinical and early molecular kinetics in pediatric chronic-phase CML receiving frontline imatinib, enabling early risk stratification to guide individualized treatment planning.

Decoupling Surface Rigidity from Bulk Compliance in Elastomeric Electrolytes via Surface-Architected MXene Interphase Engineering

Journal of the American Chemical Society Zhisong Geng, Yun Xing, Chenxi Cao et al. Jul 01, 2026 DOI: 10.1021/jacs.6c01701

Self‐Seeded Nucleation of PET in a Benign Solvent Yields a High Modulus Aerogel With Ultra‐Low Thermal Conductivity

Advanced Materials Kira R. Baugh, Garrett F. Godshall, Glenn A. Spiering et al. Jul 01, 2026 DOI: 10.1002/adma.73409

ABSTRACT Poly(ethylene terephthalate) (PET) is the most recycled plastic; however, upcycling of this commodity polymer to value‐added products has remained limited. Recent attempts to produce PET aerogels have relied on toxic solvents, chemical conversions and cross‐linking, and reinforcement to achieve useful mechanical performance. Now, using a new benign solvent (1,3‐diphenylacetone), we report a simple, safe, and sustainable dissolution and gelation procedure to convert waste PET into low density, monolithic aerogels with high mechanical strength (E = 20 ± 2 MPa) and remarkably low thermal conductivity (k = 21.9 to 28.9 mW m −1 K −1 ). The key to this process is controlled crystal nucleation by a self‐seeding phenomenon during gelation that establishes a mesoscale fibrillar framework. Our strategy offers a benign sol–gel process to upcycle plastic waste into a new form of pure PET for advanced thermal insulation.

Weakly‐Coordinating Non‐Fluorinated Diluents for Local High‐Concentration Electrolytes in Advanced Lithium Metal Batteries

Advanced Materials Yin Cui, Xinrui Li, Nan Jiang et al. Jul 01, 2026 DOI: 10.1002/adma.73388

ABSTRACT Local high‐concentration electrolytes (LHCEs) resolve the contradiction between ion transport efficiency and interface stability of traditional electrolytes in lithium metal batteries (LMBs) through the innovative design of macroscopically low viscosity and locally high concentration. Nevertheless, fluorinated diluents widely used in current LHCEs possess inherent defects, including high environmental toxicity, poor biodegradability, and high synthesis costs, which severely restrict the sustainable and large‐scale application of LMBs. Recently, non‐fluorinated diluents have attracted growing attention as viable alternatives, yet their roles remain insufficiently understood and often oversimplified as inert viscosity modifiers. In this perspective, we systematically classify non‐fluorinated diluents into chlorinated and halogen‐free systems, and further correlate their molecular structures with solvation behavior, interfacial chemistry, and electrochemical performance. By critically analyzing recent advances, we reveal that non‐fluorinated diluents are not intrinsically benign or universally inert; instead, their effectiveness arises from a delicate balance between weak interactions, transport regulation, and interphase formation. Finally, we outline key challenges and future directions, including parameter‐guided molecular design, multi‐component electrolyte engineering, advanced in situ characterization, and sustainability‐driven evaluation. This perspective aims to provide comprehensive theoretical support for the structural optimization of non‐fluorinated diluents and the innovation of electrolyte formulations, thus promoting the technological progress and industrialization of LMBs.

Ganaxolone, an approved therapy for CDKL5-deficiency disorder, is an inhibitor of PTP1B

Journal of Biological Chemistry Imanol Zubiete-Franco, Qingting Hu, Steven R. Alves et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113178

Novel triplet combination of orelabrutinib, lenalidomide, and rituximab as frontline therapy for mantle cell lymphoma: Final results of POLARIS multicenter phase II study.

Journal of Clinical Oncology Huilai Zhang Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.260

260 Background: Despite the established efficacy of chemoimmunotherapy in untreated mantle cell lymphoma (MCL), its clinical utility remains limited by suboptimal long-term outcomes and chemotherapy-associated toxicities. These challenges have driven the exploration of chemotherapy-free approaches, as pioneered by lenalidomide plus rituximab (LR). Given the potential association of enhanced response and survival with earlier incorporation of BTK inhibitors, this POLARIS study attempts to improve upon the LR regimen in these patients, by assessing the triplet incorporating orelabrutinib (called ‘OLR’), a potent and highly selective BTK inhibitor approved for lymphoma. Methods: In this multicenter, open-label phase II study, untreated MCL pts received six 28-day cycles of induction therapy with orelabrutinib (150 mg once daily) plus LR, followed by OLR maintenance for up to 18 cycles. The primary endpoint was complete response rate (CRR) at the end of the 6-cycle induction therapy (EOIT). Results: As of February 20, 2025, 29 patients (male, 89.7%; median age, 62 years) were enrolled, most with Ki67 index ≥ 30% (55.2%), and Ann Arbor stage III-IV disease (82.8%), bulky mass (58.6%). One (3.4%) and 5 (17.2%) cases had high MIPI-C and TP53 mutations, respectively. All 29 patients completed 6-cycle OLR induction, among whom 22 completed maintenance. By data cutoff, 3 (10.3%) remain in the study. Of 29 patients evaluated for efficacy, CRR and overall response rate (ORR) at EOIT were respectively 69% (95% CI, 49.2-84.7%) and 96.6% (95% CI, 82.2-99.9%). During the study, 26 (89.7%) had CR and 3 (10.3%) had a partial response as the best outcomes, for the best ORR of 100.0%. Among responders, the median time to response and duration of response were 3.0 months and not reached (NR), respectively. With 4 progressive or fatal events during a median follow-up of 29.6 months, median progression-free survival (PFS) and overall survival had not yet been reached. ctDNA positivity rate after 6 cycles was 32.1% (9/28). The most frequent mutation in tumor tissues at baseline was CCND1 . TP53 mutations were significantly correlated to PFS. Grade 3-4 treatment-related adverse events were seen in 24 (82.8%) of 29 patients and mainly included neutrophil count decreased (65.5%). Conclusions: The OLR regimen provided an encouraging clinical and molecular response and favorable safety in untreated MCL, potentially representing a highly active and less toxic chemotherapy-free option. More data will be reported from this study. Clinical trial information: NCT05076097 .

Enantioselective B–H Insertion of Branched α-Alkyl Carbenes

Journal of the American Chemical Society Cheng-Da Zhang, Chu-Xi Xu, Zhang-Wei Wang et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04295

Metal Atoms and Quantum Dots Coexist for Water Electrolysis

Advanced Materials Wenbo Deng, Feng He, Yuliang Li Jul 01, 2026 DOI: 10.1002/adma.73687

ABSTRACT How to manipulate the surface of the supports to control metal atoms is frontier research that has emerged in recent years in the field of catalysis. However, the precise and controllable synthesis of metal atom systems with well‐defined structure and valence states remains a significant challenge. Herein, based on theoretical predictions, we report a new catalytic system of GDY, where metal atoms and quantum dots coexist. Precise structural studies have determined that Ni atoms and RuNi x quantum dots (denoted as Ni–RuNi x /GDY) are distributed on GDY surface. GDY has the ability to act as an electronic medium to control the strong interaction between Ni atom and sp ‐C within a long‐range distance, leading to promote the hydrolysis abilities of Ni atom adjacent to RuNi x . The as‐synthesized Ni–RuNi x /GDY catalyst exhibits astonishing results in the alkaline hydrogen evolution reaction (HER), with overpotentials of only 17 mV and 116 mV achieving current densities of 10 and 1000 mA cm − 2 , respectively. This work presents a new method for creating highly efficient multi‐component atom catalysts, and a new concept for long‐range control of catalysis to open up new routes for the frontier research on developing advanced catalytic systems in the future.

Autoinhibition of the mechanosensitive lipid scramblase TMEM63B by its C-terminal tail

Journal of Biological Chemistry Megumi Nishimura, Yugo Miyata, Yu Shiraki et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113223

A randomized, open-label, phase II trial of short-term combination pharmacotherapy in patients receiving cytotoxic chemotherapy for solid tumors.

Journal of Clinical Oncology Beulah Elizabeth Koshy Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.305

305 Background: Patients from resource-limited settings often tolerate standard chemotherapy poorly, resulting in dose reductions, treatment delays, and hospitalizations. Baseline malnutrition, anorexia, and cancer cachexia are key contributors and frequently worsen during systemic therapy. Practical strategies to improve nutritional status and chemotherapy tolerance in this population remain limited. We evaluated short-term fixed-dose combination pharmacotherapy to improve weight, appetite, and tolerance to chemotherapy. Methods: This randomized, open-label phase 2 study enrolled 91 patients with locally advanced solid cancers and a baseline body mass index below 18 kg/m². Patients were randomized to receive fixed-dose combination pharmacotherapy consisting of megestrol acetate 800 mg per day and olanzapine 5 mg per day or placebo for up to 6 weeks prior to and during chemotherapy. Primary endpoints were weight gain, improvement in appetite, and tolerance to chemotherapy, defined as the absence of grade 3 or higher hematological or non-hematological toxicities according to CTCAE criteria. Appetite and nutritional status were assessed using the Visual Analog Scale (VAS) and Subjective Global Assessment (SGA). Results: Patients in the intervention arm demonstrated significantly greater weight gain and improved appetite compared with the placebo arm. Eighty percent of patients receiving combination pharmacotherapy achieved a weight gain of at least 5 percent from baseline within 6 weeks, with a median time to target weight of 4 weeks, whereas no patients in the placebo arm achieved similar weight gain (p value &lt; 0.01). Conversely, 8 patients in the placebo arm experienced weight loss of 5 percent or more, compared with none in the intervention arm (p = 0.001). Significant improvements in Visual Analog Scale and Subjective Global Assessment scores were observed in the intervention group compared with placebo (p = 0.001 for both). Grade 3 or higher hematological toxicities occurred in 7 patients in the placebo arm, while no such events were observed in the intervention arm (p = 0.046). Conclusions: This study highlights the potential of this low cost; novel pharmacological strategy to mitigate malnutrition, enhance chemotherapy tolerance, and improve quality of life in cancer patients from resource-limited settings.